Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus
Crossref DOI link: https://doi.org/10.1186/s12933-015-0297-x
Published Online: 2015-10-17
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fioretto, Paola
Giaccari, Andrea
Sesti, Giorgio